Scholars Central

Conference abstractPublished 2022

Obesity and endocrine resistance in breast cancer: Epidemiological evidence and proposed mechanisms

Authors: Ines Barone

University Of Calabria, Italy

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The incidence of obesity has been steadily increasing over the past few decades worldwide. This scenario has drawn particular attention from researchers due to the fact that obesity is associated with concomitant or increased risk of nearly every chronic condition, including diabetes, coronary artery disease, hypertension, kidney disease, disability, and carcinomas. In the latter regard, there is a growing appreciation that the excessive adiposity deeply influences risk, prognosis, and mortality rates of breast carcinomas. Obesity status has also profound implications on therapeutic management of patients, especially related to the efficacy of standard endocrine therapies with selective estrogen receptor modulators (SERMs) or degraders (SERDs) and aromatase inhibitors (AIs). The mechanisms underlying the link existing between obesity and endocrine therapy resistance are likely to be multifactorial. Indeed, different obesity-related host factors, such as adipokines, insulin-like growth factors pathways, inflammatory cytokines, aromatase activity, lipid metabolites, hypoxia and oxidative stress, can interact with several cancer cell-intrinsic signalings, rendering breast cancer cells resistant to endocrine treatments. Here, we will highlight the complex and not yet completely understood impact of obesity on breast cancer endocrine resistance, by providing an update of the recent epidemiological research focused on this hot topic and addressing the molecular mechanisms by which obesity-associated changes may affect breast malignancy. Given the increase in global burden of obesity, especially in developing countries undergoing rapid socio-economic changes, a more comprehensive understanding of the mechanisms underlying the obesity-endocrine resistance connection will be instrumental to reveal novel markers and more personalized oncology approaches for disease management. In the meantime, lifestyle interventions (e.g. weight loss and exercise) need to be considered as strategies for prevention and survival improvement for breast cancer patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Womens Health, Issues and Care.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Womens Health, Issues and Care
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Ines Barone”